Observational studyJournal of global oncology2019

OSSMAR: An Observational Study to Describe the Use of Sunitinib in Real-Life Practice for the Treatment of Metastatic Renal Cell Carcinoma.

Marwan Ghosn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.